Stocks close with solid gains, breaking slump

A Wall Street sign in front of the New York Stock Exchange on April 22, 2010. Credit: AP / Mark Lennihan
The stock market closed with solid gains Wednesday, led by a jumps in health-care and energy companies. Drugmakers posted especially big gains. Energy stocks rose as the price of oil shot up 5 percent.
At the close, the Dow Jones industrial average was up to 112.7, about 0.6 percent, to 17,716.1. The Standard & Poor’s 500 index added 21.5 points, about 1.1 percent, to 2,066.7. The Nasdaq composite gained 76.8 points, about 1.6 percent, to 4,920.7.
CRUDE ENERGY: About the same time, the price of U.S. benchmark crude oil was up $1.95, about 5.4 percent, at $37.84 a barrel on the New York Mercantile Exchange. In London, the price of the international benchmark oil, Brent crude, was up $1.89, about 5 percent, at $39.76 a barrel.
DRUG DEAL UNDONE: Health care stocks made the largest gains. Pfizer and Allergan both rose after they called off their $160 billion merger, as expected, after the U.S. Treasury Department introduced new tax rules that made the deal far less appealing. .
Biotechnology companies also rose. Cancer drugmaker Celgene closed up $6.10, about 6 percent, at $108.22, and Vertex Pharmaceuticals climbed $7.15, about 8.5 percent, to close at $91.31.
STELLAR SUDS: Constellation Brands rose $8.98, about 5.9 percent, to close at $160.34. The owner of Corona, Negra Modelo and Pacifico beers reported solid quarterly results and raised its profit forecasts for the year.
Tracking the nor'easter ... LIRR, PSEG prep for storm ... Landscaper electrocuted ... Trendy Bites: Iced coffee in a pumpkin
Tracking the nor'easter ... LIRR, PSEG prep for storm ... Landscaper electrocuted ... Trendy Bites: Iced coffee in a pumpkin




